KRAS and pancreatic neoplasm: Since mutations in K-Ras are nearly universal in PDAC and Gal-3 is highly expressed in pancreatic cancer cells in both human and K-Ras mutant mouse, we asked whether elevated Gal-3 levels may further mediate or augment Ras activity in pancreatic cancer cells.